BioBone – A prospective, blinded, multicenter validation study of the CD8 + terminal differentiated effector memory cells (CD8 + TEMRA cells) as prognostic biomarker for disturbed fracture healing – study design

The BioBone study will validate the suitability of CD8 + TEMRA cells as a prognostic marker for impaired fracture healing and their integration into routine clinical practice. The results could have a global impact by incorporating immune-based prognostic tools into clinical workflows, paving the way for precision medicine approaches in trauma care. The BioBone study is funded by the German Federal Ministry of Education and Research (BMBF).

Authors

Institutions

Publication Details

Journal
Journal of Orthopaedic Surgery and Research
Published
2025-06-16
DOI
https://doi.org/10.1186/s13018-025-05987-7
Citations
2
Primary Topic
Bone fractures and treatments
Type
article
Field-Weighted Citation Impact
2.71

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

BioBone – A prospective, blinded, multicenter validation study of the CD8 + terminal differentiated effector memory cells (CD8 + TEMRA cells) as prognostic biomarker for disturbed fracture healing – study design

Sven Geißler, Michael Dahne, Richard Stange, Georg Osterhoff et al.
2 citations
Journal of Orthopaedic Surgery and Research
Bone fractures and treatments
2.71
article

BioBone – A prospective, blinded, multicenter validation study of the CD8 + terminal differentiated effector memory cells (CD8 + TEMRA cells) as prognostic biomarker for disturbed fracture healing – study design

Sven Geißler, Michael Dahne, Richard Stange, Georg Osterhoff, Christian Kleber, Georg Matziolis, Andrea Bauer, Michael J. Raschke, Frederik Maximilian Schäfer, Hans‐Dieter Volk, Klaus‐Dieter Schaser, H. Wéber, Sven Märdian, Georg N. Duda, Ulrich Stöckle, Maik Stiehler, Simon Reinke, Sebastian Rohe, Denis Gümbel, Carsten Perka, Philipp Schwabe
article en
2 citations

Abstract

The BioBone study will validate the suitability of CD8 + TEMRA cells as a prognostic marker for impaired fracture healing and their integration into routine clinical practice. The results could have a global impact by incorporating immune-based prognostic tools into clinical workflows, paving the way for precision medicine approaches in trauma care. The BioBone study is funded by the German Federal Ministry of Education and Research (BMBF).

Journal of Orthopaedic Surgery and ResearchVol. 20(1)
Humboldt-Universität zu Berlin (DE), Waldkrankenhaus Rudolf Elle (DE), Hanseatic University Rostock (DE), University Hospital Münster (DE), Unfallkrankenhaus Berlin (DE), Vivantes Klinikum (DE), University Hospital Leipzig (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), BG Klinikum Bergmannstrost Halle (DE), University Hospital Carl Gustav Carus (DE), Klinik und Poliklinik für Psychotherapie und Psychosomatik (DE), University of Rostock (DE), Friedrich Schiller University Jena (DE)
Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Charité – Universitätsmedizin Berlin, Universität Leipzig, Berlin Institute of Health
Openalex Percentile: Top 10%
Bone fractures and treatments
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.